Senzime Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Employees
  • 20
Employees
  • Stock Symbol
  • SEZI
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $2.45
  • (As of Friday Closing)

Senzime General Information

Description

Senzime AB develops unique patient-oriented monitoring systems that make it possible to assess patient's biochemical and physiological processes before, during, and after surgery. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Geographically, it derives a majority of revenue from Asia and also has a presence in Europe/Oceania and the USA. Its product includes TetraGraph and TetraSens.

Contact Information

Website
www.senzime.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Monitoring Equipment
Stock Exchange
STO
Primary Office
  • Ulls väg 41
  • 756 51 Uppsala
  • Sweden
+46 0000000000

Senzime Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Senzime Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.45 $2.47 $2.02 - $3.32 $154M 62.5M 54.9K -$0.13

Senzime Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 167,069 174,709 98,120 39,482
Revenue 1,330 1,013 710 369
EBITDA (6,502) (4,010) (2,477) (2,390)
Net Income (7,663) (5,146) (3,459) (2,767)
Total Assets 25,350 31,560 14,023 15,352
Total Debt 161 292 41 88
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Senzime Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Senzime‘s full profile, request access.

Request a free trial

Senzime Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Senzime AB develops unique patient-oriented monitoring systems that make it possible to assess patient's biochemical and
Monitoring Equipment
Uppsala, Sweden
20 As of 2020
000.00
000000000 000.00

0000000

ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
0000000000 000000000
Halifax, Canada
0 As of 0000
0000
000000000000 0000

0-00000

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, su
0000000000 000000000
Uppsala, Sweden
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Senzime Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mindful Scientific Venture Capital-Backed Halifax, Canada 0 0000 000000000000 0000
0-00000 Formerly VC-backed Uppsala, Sweden 000 00000 00000000 00000
0000000 0000000 Corporate Backed or Acquired Brea, CA 00000 000000&0
0000000000 Venture Capital-Backed Los Angeles, CA 00 000.00 00000000000 000.00
000000000000 Private Equity-Backed Puteaux, France 000 000.00 000000000000
You’re viewing 5 of 8 competitors. Get the full list »

Senzime Executive Team (7)

Name Title Board Seat Contact Info
Pia Renaudin Chief Executive Officer
Erik Bergman Chief Financial Officer
Johanna Tulkki Chief Operating Officer
Anders Jacobson Chief Technology Officer
You’re viewing 4 of 7 executive team members. Get the full list »

Senzime Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Senzime Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Senzime‘s full profile, request access.

Request a free trial

Senzime Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000000 03-May-2016 000000000000000000 000.00 Monitoring Equipment 0000 0ö000000ö0
MD Biomedical 21-Apr-2015 Merger/Acquisition 00000 Diagnostic Equipment
To view Senzime’s complete acquisitions history, request access »